NCT06481839View on ClinicalTrials.gov

Impact of Starting Dose of Vasopressor on Hemodynamic Response in Shock

NANot yet recruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

July 24, 2024

Primary Completion Date

July 24, 2026

Study Completion Date

July 24, 2028

Conditions
Shock
Interventions
OTHER

Starting dose of NE

Patients will be randomized to either low-dose (5mcg/min) or high-dose (15mcg/min) norepinephrine (NE) for their first vasopressor in shock.

All Listed Sponsors
lead

University of Illinois at Chicago

OTHER

NCT06481839 - Impact of Starting Dose of Vasopressor on Hemodynamic Response in Shock | Biotech Hunter | Biotech Hunter